Efficacy of Antibody Cocktail Drug in COVID-19 Positive Patients: A Retrospective Single-centered Study

Efficacy of Antibody Cocktail Drug in COVID-19 Positive Patients: A Retrospective Single-centered Study

Introduction: Neutralising monoclonal antibodies (mABs) have been proposed and developed for the treatment of Coronavirus Disease-2019 (COVID-19) patients with mild to moderate diseases and to prevent further progression. The combination of Casirivimab and Imdevimab blocks the entry of virus into ce...

Full description

Bibliographic Details
Main Authors: Manoranjan Dash, Nursingha Charan Dash, Arun Kumar, Smrutirekha Swain, Swetaleena Ashe, Jyoti Patnaik
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
casirivimab
clinical profile
imdevimab
monoclonal antibodies
Online Access:https://jcdr.net/articles/PDF/17392/59143_CE[Ra1]new_F(IS)_PF1(AG_OM)_PFA(SS)_PB(AG_SS)_PN(SS).pdf

Internet

https://jcdr.net/articles/PDF/17392/59143_CE[Ra1]new_F(IS)_PF1(AG_OM)_PFA(SS)_PB(AG_SS)_PN(SS).pdf

Similar Items